2013-000052-17: Study to investigate the early prediction of toxicity following chemotherapy and differences in drug handling in Ewing's sarcoma patients |
|
|
| Ongoing | 4 | 120 | Europe | Cyclophosphamide, Etoposide, Doxorubicin, Vincristine, Ifosfamide, Powder for solution for injection, Concentrate for solution for infusion, Solution for infusion, Solution for injection, Powder for concentrate for solution for infusion, Cyclophosphamide, Eposin, Doxorubicin Hydrochloride, Vincristine Sulphate, Ifosfamide | The Newcastle Upon Tyne Hospitals NHS Foundation Trust | Ewing sarcoma patients, Bone cancer, Diseases [C] - Cancer [C04] | | | | |
NATARS, NCT05844813: Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma |
|
|
| Enrolling by invitation | 4 | 102 | RoW | Doxorubicin+Ifosfamide+Anlotinib(AI+A), Radical Surgery | Peking University International Hospital, Shanghai Zhongshan Hospital, The Affiliated Hospital of Qingdao University, Peking University First Hospital, Shanghai Cancer Hospital, China, First Affiliated Hospital Xi'an Jiaotong University, Beijing Friendship Hospital | Retroperitoneal Sarcoma | 11/25 | 11/27 | | |
